Faheem Arshad | Cognitive Neurosciences | Best Researcher Award

Dr. Faheem Arshad | Cognitive Neurosciences | Best Researcher Award

Dr. Faheem Arshad is an Assistant Professor of Neurology at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru. A leading cognitive neurologist in India, he specializes in dementia and neurodegenerative disorders. He played a pivotal role in establishing India’s first cognitive disorders registry at NIMHANS, integrating clinical and research excellence. Dr. Arshad is a Senior Atlantic Fellow for Equity in Brain Health at the University of California, San Francisco (UCSF), and the first fellow from South Asia. His research integrates neurogenetics, biomarkers, imaging, and clinical trials, with a focus on inclusivity and low-literacy populations. He actively contributes to national and international collaborations and holds leadership roles within Indian and global neurology communities. Committed to early diagnosis, caregiver support, and prevention strategies, his work aims to improve brain health equity in diverse settings. His ongoing studies explore social interaction, bilingualism, and digital tools in dementia management.

Profile

Education 🎓

Dr. Arshad received his foundational training in Internal Medicine (MD, 2014) at Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Kashmir. He served as Registrar in Internal Medicine at AIIMS, New Delhi until 2016. He pursued advanced neurological training at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, earning a DM in Neurology (2019) and completing a Post-Doctoral Fellowship in Cognitive Neurosciences (2020). He furthered his expertise with a prestigious international fellowship in Global Brain Health Equity at the Global Brain Health Institute (GBHI), University of California, San Francisco (UCSF), USA in 2021. Dr. Arshad also holds the MRCP(UK) Neurology credential (2020), reflecting global competence. His multidisciplinary training spans cognitive neurology, imaging, biomarkers, and dementia prevention, equipping him with a holistic approach to brain health research and patient care.

Experience 👨‍🏫

Dr. Faheem Arshad’s professional journey spans over a decade of clinical, academic, and research excellence. He is currently Assistant Professor of Neurology at NIMHANS, Bengaluru, where he has led initiatives in cognitive neurology since 2021. His early training included roles as Junior and Senior Resident in Internal Medicine at SKIMS and AIIMS, followed by Neurology Residency and Postdoctoral Fellowship at NIMHANS. He became a faculty leader and Convener of the Cognitive Neurology subsection of the Indian Academy of Neurology in 2023. Internationally, he served as an Atlantic Fellow at UCSF’s GBHI (2020–2021), developing leadership in brain health equity. Dr. Arshad is a member of the American Academy of Neurology and other prestigious forums. He has published widely, initiated clinical trials, and built registries that bridge clinical insights with translational research. His work integrates social science, neurobiology, and global health in addressing dementia across underserved populations.

Awards & Recognitions 🏅

Dr. Faheem Arshad has received numerous recognitions for his contributions to neurology and dementia research. He was awarded the Bursary Award at the TSS International Neuropsychiatry Conference (2018) for his work on social cognition in Frontotemporal Dementia. As the first South Asian to become a Senior Atlantic Fellow for Equity in Brain Health at UCSF’s GBHI, he has been globally recognized for championing equity in dementia care and research. His appointment as Convener of the Cognitive Neurology subsection by the Indian Academy of Neurology in 2023 highlights his leadership within the national academic community. He holds the MRCP(UK) in Neurology and is an active member of prestigious societies, including the American Academy of Neurology. These honors reflect his ongoing commitment to research innovation, community-based care models, and international collaboration in the field of neurodegenerative disorders.

Research Interests 🔬

Dr. Faheem Arshad’s research focuses on dementia, particularly Frontotemporal Dementia (FTD), Alzheimer’s Disease, and related neurodegenerative conditions. He investigates cognitive reserve, biomarkers, social cognition, neuroimaging, and bilingualism in dementia resilience. His landmark projects include exploring the role of social interaction in FTD (GBHI-AA), plasmapheresis in Alzheimer’s (ICMR), cognitive testing in low-literacy settings, and bilingualism’s impact on cognitive reserve (NIH-funded). He co-leads a SERB-funded project using speech features for early dementia detection and a DBT-funded imaging study for vascular dementia diagnosis. He established India’s first cognitive disorders registry at NIMHANS, integrating socio-demographics, imaging, and biomarker data. His work bridges clinical neurology and public health, emphasizing inclusive research for underrepresented populations. A strong advocate for clinical trials in LMICs, his studies integrate AI tools, cross-cultural data, and longitudinal analyses to improve early diagnosis and therapeutic strategies in dementia care.

Publications

Arunachalam Muthuraman | Cognitive Neuroscience | Best Researcher Award

Dr. Arunachalam Muthuraman | Cognitive Neuroscience | Best Researcher Award 🏆

Information Technology at   Duhok Polytechnic University🎓

Dr. Arunachalam Muthuraman is an Associate Professor in the Pharmacology Unit at AIMST University, Malaysia, with over 13 years of experience in pharmaceutical sciences. He holds an M. Pharm in Pharmacology and a Ph.D. in Neuropharmacology from Punjabi University, India. His research focuses on renal pharmacology, neuropharmacology, toxicology, cancer cell biology, and herbal technology. Dr. Muthuraman has published 84 research papers, 18 review articles, and authored multiple book chapters. His work has earned him prestigious recognitions, including the Elsevier Top 2% Scientist Rank in 2024 and the Global Top-50 Academician Award in 2023. He has guided numerous students, including Ph.D. candidates, and has contributed significantly to international conferences and workshops. Dr. Muthuraman is passionate about advancing pharmaceutical science and nurturing future researchers.

Professional Profile 

Education 🎓:

Dr. Arunachalam Muthuraman holds a Bachelor of Pharmacy (B.Pharm) from The Tamilnadu Dr. MGR Medical University (2001-2005), a Master of Pharmacy (M.Pharm) in Pharmacology from Punjabi University (2005-2008), and a Ph.D. in Neuropharmacology from the same university (2008-2012). His academic foundation laid a strong base for his deep dive into pharmacology, particularly in neuropharmacology, renal pharmacology, and toxicology.

Work Experience 💼:

With over 13 years of academic experience, Dr. Muthuraman is currently an Associate Professor at AIMST University, Malaysia (2023-present), specializing in pharmacology. He has also held positions as Assistant Professor and Senior Lecturer in the Pharmacology Unit at AIMST University, demonstrating significant leadership and contributions to pharmacology education. Prior to this, he worked as an Associate Professor and Head of the Akal Pharmacology & Toxicology Research Centre at Akal College of Pharmacy, India.

Skills 🔍

Dr. Muthuraman is skilled in diverse areas of pharmacology, including renal pharmacology, neuropharmacology, toxicology, and cancer cell biology. His expertise spans cellular and molecular pharmacology, cardiovascular pharmacology, and herbal technology, with a focus on drug research and development, clinical pharmacology, and technology-enhanced therapeutic solutions.

Awards and Honors 🏆

Dr. Muthuraman has received prestigious recognitions, such as Elsevier’s Top 2% Scientist Rank in 2024, acknowledging his high impact research publications. He was also named in the Global Top-50 Academicians & Researchers of 2023 for his outstanding contributions to pharmaceutical sciences. Additionally, he was awarded the International Achievement Award in 2023 for his research contributions in pharmaceutical science.

🤝 Memberships:

Dr. Muthuraman is actively involved in several international scientific communities and academic organizations, reflecting his dedication to advancing pharmaceutical research and education.

Teaching Experience 👩‍🏫:

As a passionate educator, Dr. Muthuraman has guided numerous students at the Ph.D., M.Pharm, and B.Pharm levels. He has supervised 9 Ph.D. students, 25 M.Pharm students, and 39 B.Pharm students, contributing to the academic and professional growth of his students. His teaching focuses on imparting knowledge in pharmacology, toxicology, and drug research.

Research Focus 🔬:

Dr. Muthuraman’s research is primarily focused on neuropharmacology, renal pharmacology, and toxicology, with an emphasis on discovering novel drug therapies for chronic diseases and cancer. His research on cellular & molecular pharmacology and the integration of herbal technology in drug development is also pioneering. He has published 84 research papers, authored 2 books, and contributed to numerous book chapters, demonstrating his leadership in academic research.

Conclusion 

Dr. Arunachalam Muthuraman is an outstanding candidate for the Best Researcher Award, with his exceptional track record in pharmaceutical sciences, his contributions to advancing pharmacological research, and his commitment to mentoring future scholars. His continuous drive for excellence and innovative approach to research makes him a deserving recipient of this prestigious award.

📚 Publilcation

    1. Therapeutic investigation of beta-carotene on diabetic retinopathy associated Alzheimer’s disease progression via the regulation of reactive glial cell functions in diabetic mice
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: Y Paramaswaran, A Muthuraman
    2. Beta-carotene ameliorates vascular dementia via modulation of homocysteine and endothelial nitric oxide synthase expression in diabetic rats
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: KG Lim, A Muthuraman
    3. Therapeutic potential of beta-carotene on intracisternal injection of glucose oxidase-induced senile dementia in diabetic rats
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: A Muthuraman, KG Lim
    4. Traditional Therapies Involving Nutrition for the Management of COVID-19
      • Year: 2024
      • Journal: Coronaviruses 5 (2), 40-48
      • Authors: R Muthusamy, A Muthuraman, K Anand
    5. NEUROBEHAVIORAL AND NEUROCHEMICAL EVALUATION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR–GEFITINIB IN Β-AMYLOID OLIGOMER INDUCED ALZHEIMER’S DISEASE IN MICE MODEL
      • Year: 2024
      • Journal: Journal of Digital Economy 3 (1), 1-12
      • Authors: J Dhamodharan, G Sekhar, A Muthuraman
    6. Ameliorative potential of Astaxanthin on glyphosate-induced neurocognitive functional changes in adult zebrafish via acid phosphatase and annexin A2 dysfunction
      • Year: 2024
      • Journal: World 6 (01), 008-019
      • Authors: KZ Xuan, N Perveen, NH Khan, A Muthuraman
    7. Ameliorative potential of thymoquinone in four vessel occlusion induced vascular dementia in rats
      • Year: 2023
      • Journal: Alzheimer’s & Dementia 19, e071053
      • Authors: N Rishitha, A Muthuraman
    8. Preventive Action of Beta-Carotene against the Indoxyl Sulfate-Induced Renal Dysfunction in Male Adult Zebrafish via Regulations of Mitochondrial Inflammatory and β-Carotene
      • Year: 2023
      • Journal: Biomedicines 11 (10), 2654
      • Authors: A Muthuraman, ASM Sayem, S Meenakshisundaram, N Ali, SF Ahmad, et al.